Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
This study has been completed.
Study NCT00000479 Information provided by Brigham and Women's Hospital
First Received on October 27, 1999. Last Updated on June 12, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiovascular Diseases
Cerebrovascular Disorders
Coronary Disease
Heart Diseases
Myocardial Infarction
Myocardial Ischemia
Vascular Diseases
Additional conditions recognized in this trial
Coronary Artery Disease
Infarction
Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Brain Diseases
Central Nervous System Diseases
Necrosis
Nervous System Diseases
Pathologic Processes
Interventions listed in this trial
Aspirin
Vitamin E
Placebo
Additional drug interventions recognized in this trial
Alpha-Tocopherol
Tocopherols
Tocotrienols
Vitamins
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antioxidants
Antipyretics
Antirheumatic Agents
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Growth Substances
Hematologic Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Protective Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Brigham and Women's Hospital
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
Back to top of Main Content
